Aprameya Engineering IPO vs Clinitech Laboratory IPO

Comparision between Aprameya Engineering IPO and Clinitech Laboratory IPO.

IPO Details

Aprameya Engineering IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Clinitech Laboratory IPO is a SME Fixed Price Issue proposed to list at BSE SME.

	Aprameya Engineering IPO	Clinitech Laboratory IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Book Built Issue	Fixed Price Issue
Listing At	NSE SME	BSE SME
Lead Managers	Hem Securities Limited	Inventure Merchant Banker Services Pvt Ltd
Registrar	Link Intime India Private Ltd	Bigshare Services Pvt Ltd
Market Maker	Hem Finlease Private Limited	Svcm Securities Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Aprameya Engineering IPO is up to ₹29.23 Cr whereas the issue size of the Clinitech Laboratory IPO is up to ₹5.78 Cr. The final issue price of Aprameya Engineering IPO is ₹58.00 per share and of Clinitech Laboratory IPO is ₹96.00 per share.

	Aprameya Engineering IPO	Clinitech Laboratory IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹56.00 per share
Issue Price (Upper)	₹58.00 per share
Issue Price (Final)	₹58.00 per share	₹96.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	2000 shares	1200 shares
Fresh Issue Size	50,40,000 shares	6,02,400 shares
Fresh Issue Size (Amount)	up to ₹29.23 Cr	up to ₹5.78 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	50,40,000 shares	6,02,400 shares
Issue Size Total (Amount)	up to ₹29.23 Cr	up to ₹5.78 Cr

IPO Timetable

Aprameya Engineering IPO opens on Jul 25, 2024, while Clinitech Laboratory IPO opens on Jul 25, 2024. The closing date of Aprameya Engineering IPO and Clinitech Laboratory IPO is Jul 29, 2024, and Jul 29, 2024, respectively.

	Aprameya Engineering IPO	Clinitech Laboratory IPO
Anchor Bid Date	Jul 24, 2024
Issue Open	Jul 25, 2024	Jul 25, 2024
Issue Close	Jul 29, 2024	Jul 29, 2024
Basis Of Allotment (Tentative)	Jul 30, 2024	Jul 30, 2024
Initiation of Refunds (Tentative)	Jul 31, 2024	Jul 31, 2024
Credit of Share (Tentative)	Jul 31, 2024	Jul 31, 2024
Listing date (Tentative)	Aug 01, 2024	Aug 01, 2024
Anchor Lockin End date 1	Aug 29, 2024
Anchor Lockin End date 2	Oct 28, 2024

Financials

Aprameya Engineering IPO P/E ratio is 23.49, as compared to Clinitech Laboratory IPO P/E ratio of 43.45.

Aprameya Engineering IPO

Clinitech Laboratory IPO

Financial

Aprameya Engineering Limited Financial Information (Restated)

Aprameya Engineering Limited's revenue decreased by -16.23% and profit after tax (PAT) dropped by -35.62% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,560.42	6,189.03	4,870.84
Revenue	6,562.22	7,833.35	20,026.16
Profit After Tax	345.67	536.92	1,661.91
Net Worth	2,336.76	1,992.49	1,452.94
Reserves and Surplus	936.76	592.49	752.94
Total Borrowing	4,204.83	2,873.95	1,368.28
Amount in ₹ Lakhs

Clinitech Laboratory Limited Financial Information (Restated)

Clinitech Laboratory Limited's revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	560.79	603.33	368.74	273.32
Revenue	643.92	636.34	645.70	459.63
Profit After Tax	37.12	61.31	51.26	40.24
Net Worth	354.80	238.08	184.81	139.03
Reserves and Surplus	186.80	88.08	34.81	72.37
Total Borrowing	86.31	102.91	88.61	53.67
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

100.00%

83.63%

Promoter Shareholding (Post-Issue)

73.53%

61.56%

P/E Ratio

23.49

43.45

Market Cap

₹110.43 Cr.

₹21.91 Cr.

ROE

15.97%%

ROCE

9.60%%

Debt/Equity

1.8

0.24

EPS

₹2.47

₹2.21

RoNW

14.79%%

10.46%%

Shares Offered

In the Aprameya Engineering IPO retail investors (RII) are offered 16,76,000 shares while in Clinitech Laboratory IPO retail investors are offered 16,76,000 shares. Qualified institutional buyers (QIB) are offered 9,58,000 shares in Aprameya Engineering IPO and 0 shares in Clinitech Laboratory IPO.

	Aprameya Engineering IPO	Clinitech Laboratory IPO
Anchor Investor Reserveration	14,34,000 shares
Market Maker Reserveration	2,54,000 shares	31,200 shares
QIB	9,58,000 shares	0 shares
NII	7,18,000 shares	3,01,200 shares
RII	16,76,000 shares	3,01,200 shares
Employee	0 shares	0 shares
Others
Total	33,52,000 shares	5,71,200 shares

Bids Received (Subscription)

Aprameya Engineering IPO subscribed 192.57x in total, whereas Clinitech Laboratory IPO subscribed 38.96x.

	Aprameya Engineering IPO	Clinitech Laboratory IPO
QIB (times)	90.29x
NII (times)	339.99x	23.28x
Big NII (times)
Small NII (times)
RII (times)	187.88x	49.61x
Employee (times)
Other (times)
Total (times)	192.57x	38.96x

Compare with others

Aprameya Engineering IPO	Clinitech Laboratory IPO
Bulkcorp IPO	Esprit Stones IPO
Sathlokhar Synergys E&C Global IPO	S A Tech Software India IPO
Trom Industries IPO	Aprameya Engineering IPO
Esprit Stones IPO	Manglam Infra And Engineering IPO
S A Tech Software India IPO	Chetana Education IPO
Manglam Infra And Engineering IPO	VVIP Infratech IPO
Chetana Education IPO	V.L.Infraprojects IPO
Clinitech Laboratory IPO	RNFI Services IPO
VVIP Infratech IPO	Macobs Technologies IPO
V.L.Infraprojects IPO	Kataria Industries IPO

Comments

Add a public comment...